Skip to main content

Peer Review reports

From: Within-class differences in cancer risk for sulfonylurea treatments in patients with type 2 diabetes (ZODIAC-55) – a study protocol

Original Submission
11 Apr 2017 Submitted Original manuscript
30 May 2017 Author responded Author comments - Dennis Schrijnders
Resubmission - Version 2
30 May 2017 Submitted Manuscript version 2
8 Jun 2017 Author responded Author comments - Dennis Schrijnders
Resubmission - Version 3
8 Jun 2017 Submitted Manuscript version 3
Publishing
14 Jun 2017 Editorially accepted
23 Jun 2017 Article published 10.1186/s12885-017-3433-z

You can find further information about peer review here.

Back to article page